具體要求： 求購(gòu)2000版中國(guó)藥典2002增補(bǔ)本標(biāo)準(zhǔn) 1.文件格式為PDF，帶封面，無(wú)加密 2.無(wú)水印 3.完整無(wú)缺頁(yè) 4.合格的2000版中國(guó)藥典2002增補(bǔ)本標(biāo)準(zhǔn) 50 有意向者可聯(lián)系我。   [更多]

條形碼數(shù)據(jù)包懸賞2交稿   [更多]

標(biāo)題： 1.Pharmacokinetics of a Single 150-mg Intravenous Infusion of Fosaprepitant: Effects of Concentration and Infusion Time in Healthy Japanese Men 作者：Azuma, Junichi 1;Fukase, Hiroyuki 2 刊名：Clinical Pharmacology in Drug Development 出版日期：2013 期號(hào)：No.4 卷號(hào)：Vol.2 2.Pharmacokinetic evaluation of fosaprepitant dimeglumine 作者：Colon-Gonzalez F;Kraft WK. 刊名：Expert Opinion on Drug Metabolism and Toxicology 出版日期：2010 期號(hào)：No.10 卷號(hào)：Vol.6 3.Pharmacokinetics of Oral Dexamethasone and Midazolam When Administered With Single-Dose Intravenous 150 mg Fosaprepitant in Healthy Adult Subjects 作者：Dr Thomas C. Marbury MD1,*;Ms Phung L. Ngo MS2;Mr Craig R. Shadle MS2;Dr Bo Jin PhD2;Ms Deborah Panebianco MS2;Dr Luzelena Caro PhD2;Dr Jack Valentine PhD2,3;Dr Gail Murphy MD2 刊名：J Clin Pharmacol 出版日期：2011 卷號(hào)：Vol.51 4.A Single-Dose Bioequivalence and Food Effect Study With Aprepitant and Fosaprepitant Dimeglumine in Healthy Young Adult Subjects 作者：Craig R. Shadle1,*;M. Gail Murphy1;Yang Liu2;Maureen Ho1;Daniel Tatosian3;Susie (Xiujiang) Li3;Robert A. Blum4 刊名：Clinical Pharmacology in Drug Development 出版日期：2012 期號(hào)：No.3 卷號(hào)：Vol.1 5.Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy 作者：Bernardo Rapoport;Teresa Smit 刊名：Expert Opinion on Drug Safety 6.Aprepitant and Fosaprepitant Drug Interactions: A Systematic Review. 作者：Patel P;Leeder JS;Piquette-Miller M;Dupuis LL. 刊名：Br J Clin Pharmacol 出版日期：2017 7.Tolerability of fosaprepitant and bioequivalency to aprepitant in healthy subjects. 作者：Dr Kenneth C. Lasseter MD1,*;Dr Jay Gambale PharmD2;Dr Bo Jin PhD2;Dr Art Bergman PhD2;Mr Marvin Constanzer MS2;Mr James Dru MS2;Dr Tae H. Han PhD2;Dr Anup Majumdar PhD2;Dr Judith K. Evans MD2;Dr M. Gail Murphy MD2 刊名：The Journal of Clinical Pharmacology 出版日期：2007 期號(hào)：NO.7 卷號(hào)：Vol.47 8.Prevention of chemotherapy-induced nausea and vomiting:focus on fosaprepitant 作者：Ian N Olver 刊名：Ther Clin Risk Manag 出版日期：2008 期號(hào)：No.2 卷號(hào)：Vol.4   [更多]

求購(gòu)注射用達(dá)托霉素藥品注冊(cè)標(biāo)準(zhǔn)：JX20150074 如果有可聯(lián)系托管   [更多]

具體要求： 1安全風(fēng)險(xiǎn)分析報(bào)告 2備案表 3品技術(shù)要求 4成品檢驗(yàn)報(bào)告 5臨床評(píng)價(jià) 6 產(chǎn)品說(shuō)明書及最小銷售單元標(biāo)簽設(shè)計(jì)樣稿 7生產(chǎn)制造信息 8符合性聲明 只需要光子冷凝膠的全套備案資料即可。   [更多]

USP  2022  枸櫞酸西地那非質(zhì)量標(biāo)準(zhǔn)   官方的   上面帶有官方日期等。   [更多]

急需“Sertraline hydrochloride”《 EP9.4 》的藥典標(biāo)準(zhǔn)一份.謝謝   [更多]

具體要求：PDF文件 要求時(shí)間：請(qǐng)?jiān)?020.08.13 24:00前交稿 交稿方式：直接點(diǎn)擊交稿在線交稿就是了，我會(huì)每天過(guò)來(lái)看的，謝謝各位藥智的戰(zhàn)友們   [更多]

查詢最新的EP和USP，Pregabalin   [更多]

文獻(xiàn)標(biāo)題: 1.Micronization of Active Pharmaceutical Ingredients (API) – from R&D to the production scale 作者：S Mende 2. Crit Care Med. 2011 Feb;39(2):259-65. doi: 10.1097/CCM.0b013e3181feeb15. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Boyd JH1, Forbes J, Nakada TA, Walley KR, Russell JA. 3. Crit Care Med. 2006 Feb;34(2):344-53. Sepsis in European intensive care units: results of the SOAP study. Vincent JL1, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D; Sepsis Occurrence in Acutely Ill Patients Investigators. 4.Pharmacokinetic comparison and bioequivalence evaluation of?losartan/ hydrochlorothiazide tablet between Asian Indian and Japanese volunteers. Kumar S,?Monif T,?Khuroo A,?Reyar S,?Jain R,?Singla AK,?Kurachi K. 5.Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics 6.Dev Sci. 2014 Nov;17(6):977-83. doi: 10.1111/desc.12171. Epub 2014 Mar 17. Follow the liar: the effects of adult lies on children's honesty. Hays C1, Carver LJ. 7.Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects. 要求: 打包上傳符合要求的文獻(xiàn)的PDF格式   [更多]